GlassScriptPhysician profile
Monther Altiti
NPI 1043737406
$10,662.42
in general payments reported to CMS, 2019-2025
11 companies · $7,438 in 2025
The $7,438 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $11.14 · 2021: $113 · 2022: $1,112 · 2023: $17.79 · 2024: $1,603 · 2025: $7,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $3,954 · Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $3,953.70 |
| Food and Beverage | $605.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,611.54 | 2022-2025 | |
| Globus Medical, INC. | $2,648.58 | 2024-2025 | Alif |
| Davol INC. | $1,782.44 | 2024-2025 | Phasix Mesh |
| Tei Biosciences INC | $157.16 | 2019 | |
| Tela Bio, INC. | $113.06 | 2021 | |
| Sanofi-Aventis U.S. LLC | $110.00 | 2025 | |
| Mallinckrodt Enterprises LLC | $107.20 | 2019 | |
| Kci USA, INC. | $83.79 | 2019 | |
| Shire North American Group INC | $19.72 | 2019 | |
| Medtronic, INC. | $17.79 | 2023 | Ligasure |
| Musculoskeletal Transplant Foundation INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monther Altiti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.